Fagron N.V.
A global pharmaceutical compounding company focused on personalized medicine.
FAGR | BR
Overview
Corporate Details
- ISIN(s):
- BE0003874915
- LEI:
- 549300TRKRUFK2RRG779
- Country:
- Belgium
- Address:
- Venecoweg 20A, 9810 Nazareth
- Website:
- https://fagron.com/
- Sector:
- Manufacturing
Description
Fagron N.V. is a global company active in pharmaceutical compounding, focusing on the delivery of personalized medicine. The company optimizes and innovates compounding to widen the therapeutic options for prescribers worldwide. Fagron develops, markets, and distributes pharmaceutical raw materials, equipment, and specially formulated vehicles and bases, such as the Pentravan® transdermal base and the SyrSpend® range of oral suspending vehicles. Its primary customers are hospitals, pharmacies, and clinics. The company also operates in the field of genomics to further support personalized healthcare solutions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-11-10 07:46 |
Disclosure of notification received from BNP Paribas Asset Management SA
|
Dutch | 100.8 KB | ||
| 2023-11-09 18:00 |
BNP Paribas Asset Management SA - Transparency notification (upward crossing) 3…
|
French | 278.9 KB | ||
| 2023-11-09 18:00 |
Disclosure shareholder notification BNP Paribas Asset Management SA.pdf
|
English | 102.6 KB | ||
| 2023-11-09 18:00 |
Aankondiging aandeelhoudernotificatie BNP Paribas Asset Management SA.pdf
|
Dutch | 100.8 KB | ||
| 2023-10-12 07:40 |
Continued strong third quarter performance with 11% topline growth to €191 mill…
|
English | 233.7 KB | ||
| 2023-10-12 07:40 |
Continued strong third quarter performance with 11% topline growth to €191 mill…
|
English | 238.2 KB | ||
| 2023-10-12 07:00 |
Continued strong third quarter performance with 11% topline growth to €191 mill…
|
English | 233.7 KB | ||
| 2023-10-12 07:00 |
Aanhoudend sterke prestaties derde kwartaal met 11% omzetgroei naar €191 miljoe…
|
Dutch | 238.2 KB | ||
| 2023-09-20 07:42 |
Fagron completes share buy-back program
|
English | 91.4 KB | ||
| 2023-09-20 07:42 |
Fagron completes share buy-back program
|
English | 98.4 KB | ||
| 2023-09-19 18:10 |
Fagron weekly progress share buy-back - completed 19 September 2023.pdf
|
English | 433.2 KB | ||
| 2023-09-19 18:10 |
Fagron completes share buy back program.pdf
|
English | 98.4 KB | ||
| 2023-09-19 18:10 |
Fagron rondt aandeleninkoopprogramma af.pdf
|
Dutch | 91.4 KB | ||
| 2023-09-18 08:17 |
Progress share buy-back program Fagron
|
English | 90.9 KB | ||
| 2023-09-18 08:17 |
Progress share buy-back program Fagron
|
English | 96.3 KB |
Automate Your Workflow. Get a real-time feed of all Fagron N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Fagron N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Fagron N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-05-23 | Pulido Andrew | Executive member | Sell | 85,000 | 1,803,351.50 EUR |
| 2025-05-22 | Pulido Andrew | Executive member | Buy | 85,000 | 1,617,550.00 EUR |
| 2025-05-02 | De Jong Cornelia Neeltje | Board | Sell | 12,689 | 263,834.55 EUR |
| 2025-04-30 | De Jong Cornelia Neeltje | Board | Sell | 229 | 4,660.15 EUR |
| 2025-04-29 | De Jong Cornelia Neeltje | Board | Sell | 10,000 | 201,500.00 EUR |
| 2025-03-28 | J. Verlinden | Other | Buy | 24,551 | 453,702.48 EUR |
| 2025-03-28 | J. Verlinden | Other | Sell | 17,930 | 344,047.56 EUR |
| 2025-03-27 | Padilla Rafael | Board | Buy | 78,469 | 1,450,107.12 EUR |
| 2025-03-27 | De Jong Cornelia Neeltje | Board | Buy | 45,418 | 839,324.64 EUR |
| 2025-02-21 | Bakker Vera | Executive member | Buy | 773 | 15,000.00 EUR |
Peer Companies
